All Videos

CSU links to autoimmune disease and mental health burden; learn from Nicholas Brownstone, MD, on key screening tips, symptom clues, and how it differs from inducible hives.

In " Skin Clearance and PsA Prevention with Biologics in Psoriasis," Dr. Strober distills the discussion into practical guidance for the clinic.

In this first episode, Joshua Zeichner, MD, shares how to spot early male pattern thinning, why it affects confidence, and which proven treatments beat social media hype.

Lisa Swanson, MD, joins Don't Be Rash host Andrew C. Krakowski, MD, for Psoriasis Awareness Month to discuss how pediatric psoriasis is often misdiagnosed and when it signals a heightened risk of psoriatic arthritis in kids.

Lisa Weiss, PA, discussed timely immunodermatology education, standout sessions, and the collaborative community at Elevate-Derm.

Shawn Demehri, MD, PhD, discussed immunomodulatory and antigen-directed immunotherapy approaches for skin cancer prevention in a recent Dermatology Times interview.

Eileen Cheever, MPAS, PA-C, discussed patient advocacy, mentorship, and improving dermatologic care across different stages of life.

Kimberly Madison, DNP, discussed how dermatology education can help nurses strengthen documentation, patient education, triage, and access to care.

Daniel Butler, MD, shares practical considerations for NPs and PAs treating psoriasis in older adults, from counseling to treatment access.

Justin Love, PA, discussed the role of emotional intelligence, communication, and preparation when navigating difficult patient conversations.

In the third case, Dr. Tina Bhutani-Jacques introduces a 34-year-old man with longstanding plaque psoriasis involving approximately 2% body surface area who remains frustrated by recurrent flares and visible plaques despite previous treatment with topical corticosteroids.

Derm Dispatch host Renata Block, DMSc, MMS, PA-C, and Obehi Oriaifo, DNP, FNP-BC, DCNP, founder of DermaNP Solutions, discuss barriers driving demand for teledermatology in rural and underserved communities.

In this segment, Dr. Tina Bhutani-Jacques expands on the rationale for selecting roflumilast 0.3% foam for a patient with plaque psoriasis affecting both the scalp and body.

Shawn Demehri, MD, PhD, discussed a topical combination immunotherapy being studied for skin cancer prevention in high-risk patients.

Stephanie Kauffman, chief executive officer of the Melanoma Research Alliance, discussed funding strategy, early career researcher support, and melanoma prevention in a recent Dermatology Times interview.

Twelve years of inconsistent care have left this patient reluctant to even be in the room. The panel sets short- and long-term goals for HS.

Choosing between TNF and IL-17 inhibition is only part of the picture. The panel maps out comorbidity screening, pain management, and where cannabis fits in.

Daniel Butler, MD, discusses the 5Ms of geriatric care, shared decision-making, deprescribing, and emerging approaches to chronic itch.

Lisa Weiss, PA-C, discussed why continuous learning and conference attendance remain valuable for dermatology PAs at every career stage.

"Reading the Risankizumab Claims Data: Protopathic Bias and Study Limitations" weighs what the data can and cannot support.

Heather Woolery-Lloyd, MD, discusses how new linear hair growth rate data translates into real-world results for patients.

Victoria Garcia-Albea, NP, discussed the learning curve for dermatology NP fellows and how continued education parallels the evolution of the specialty.

Eileen Cheever, PA, shared how mentorship, experienced colleagues, and conference attendance can support professional growth and patient care.

Heather Woolery-Lloyd, MD, reviews a new clinical study quantifying linear hair growth rate across 4 Nutrafol formulations.

In this episode, Dr. Tina Bhutani-Jacques presents the second case, featuring a 45-year-old woman with plaque psoriasis affecting both the scalp and body.

In this segment, Dr. Tina Bhutani-Jacques discusses the clinical rationale for transitioning patients with plaque psoriasis to newer nonsteroidal topical therapies when previous treatments have provided inadequate efficacy or tolerability.

In the new episode of Don't Be Rash, learn why early pulsed dye laser helps pediatric PWCMs, what drives recurrence, and which new therapies may boost results.

Stephanie Kauffman, CEO of the Melanoma Research Alliance, discussed the organization's research priorities as it approaches 20 years of advancing melanoma research.

Goran Mićević, MD, PhD, joined Christopher Bunick, MD, PhD, to discuss phase 3 findings showing an individualized mRNA neoantigen therapy improved outcomes with checkpoint blockade in resected melanoma.

Alexandra Richmond, MD, explains realistic hair-loss timelines, scarring alopecia limits, combination therapies, PRP and supplements, plus promising insights on extended‑release oral minoxidil.